The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,064.00
Bid: 1,056.00
Ask: 1,064.00
Change: 12.00 (1.14%)
Spread: 8.00 (0.758%)
Open: 1,056.00
High: 1,078.00
Low: 1,056.00
Prev. Close: 1,052.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA

13 Nov 2023 14:02

RNS Number : 2747T
Savills PLC
13 November 2023

SAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA

LONDON, 13 November 2023 - Savills North America has appointed David Lipson as its new Chief Executive Officer effective 1 January 2024. David replaces Mitch Rudin who has been CEO since July 2020 and becomes Chairman of Savills North America on David's appointment

David has been with Savills North America (and its predecessor firm Studley Inc.) since 1987, and until his appointment as President of Savills North America in January 2021 headed its successful Washington office.

In his new role, David will be responsible for leading the next stage of Savills North America's growth. David will continue to represent North America as a member of the Savills plc Group Executive Board. Mitch Rudin will retire from this Board effective 31 December 2023.

Mark Ridley, Chief Executive Officer at Savills plc, commented:

"I am delighted that David will become the new CEO of Savills North America effective 1 January 2024. His experience will be instrumental in leading a strong management team to deliver our growth aspirations for the business over the coming years.

I would also like to thank Mitch Rudin for his significant contribution to Savills North America since July 2020, and in particular his leadership of the business during the Covid pandemic. I am very pleased that we will continue to be able to draw on Mitch's experience in his new role as Chair of Savills North America.

I very much look forward to continuing to work with both David and Mitch in their new roles."

David Lipson, CEO Savills North America commented:

"Savills has been much more than a work place for me and since joining as a summer intern in 1987, it has truly been an honour in helping develop the business and I look forward to guiding it into the future. I am also confident of its continued success thanks to the exceptional professionals within our platform, who will be instrumental in shaping the future of real estate advisory, despite the market challenges."

ENDS

For further information contact:

Savills plc

Mark Ridley/Simon Shaw Tel: +44 (0)20 7409 8934

Teneo Communications

Elizabeth Snow

Tel: +44 (0)20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOABJBITMTMBBMJ
Date   Source Headline
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice
30th Mar 20237:47 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.